BIOLARGO, INC. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.

Public ticker
BLGO on OTC
Latest financial report
15 May 2026
Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Westminster, CA
SEC filing record 1 source field available
Fiscal year end
31 December

Shareable Research Card

BLGO - BIOLARGO, INC. Financial Facts

BLGO - BIOLARGO, INC. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q1 2026
Latest reported value
Current Ratio 1.1x

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub

Return Loop

Why revisit this company facts page

Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.

Latest source-backed update
Latest metrics period Q1 2026
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
  • Current latest metrics period: Q1 2026.
  • Most recent SEC facts end date on this page: 29 Apr 2026.
  • Save this filer to return when the next filing-backed metric period changes the picture.

Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.

Create account to save this filer Open latest 10-Q/10-K hub

Latest update

Latest update for BLGO - BIOLARGO, INC.

New fact period available

Latest financial period: Q1 2026. Reopen this facts page to verify the newest reported period against the prior baseline.

Update date

15 May 2026

Page type

Company facts

Latest period

Q1 2026

SEC-backed company facts were refreshed from filings filed on 15 May 2026.

Open recent updates hub Open latest 10-Q/10-K hub

Benchmark Context

How Current Ratio compares

Current Ratio is down about 48% versus the comparable prior period.

Compared with

Compared with BIOLARGO, INC.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.

Why this is notable

Current Ratio already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.

  • Latest comparable period on this page: Q1 2026.
  • Peer context will appear when enough companies report a comparable value for this metric.
  • Open the metric history first if you want to verify the exact period-to-period change.

Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.

Open latest 10-Q/10-K hub

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Key facts

  • BLGO - BIOLARGO, INC. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2026.
  • Headline metric: Current Ratio 1.1x.

Change

  • Current Ratio YoY change: -48%.
  • Most recent SEC facts end date: 29 Apr 2026.

Research use

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

View source filing

Latest SEC snapshot (2026-04-29) highlights Current Ratio 1.1x and Quick Ratio 0.98x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

100.0/100

Strong Confidence low

Financial Health

Current Ratio
1.1x
Quick Ratio
0.98x

Strengths

Current Ratio and Quick Ratio

Watchpoints

No major risk flags from available metrics.

Key metrics snapshot

Financial Health

Metric Latest value YoY change
Current Ratio 1.1x -48%
Quick Ratio 0.98x -51%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 320,883,262 +6.5%
Common Stock, Value, Issued $214,000 +5.9%
Weighted Average Number of Shares Outstanding, Basic 318,698,686 +5.8%

Supporting Metrics

These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.

Metric Latest value YoY change
Accounts Payable, Current $838,000 -27%
Accounts Receivable, after Allowance for Credit Loss, Current $730,000 -83%
Accumulated Other Comprehensive Income (Loss), Net of Tax $209,000 -3%
Additional Paid in Capital $165,347,000 +4.5%
Assets $8,565,000 -19%
Assets, Current $5,445,000 -25%
Cash and Cash Equivalents, at Carrying Value $4,122,000 +61%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $239,000
Common Stock, Par or Stated Value Per Share 0.0007 0%
Common Stock, Shares Authorized 550,000,000 0%
Common Stock, Shares, Issued 319,699,928 +5.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,917,000 -308%
Contract with Customer, Liability, Current $319,000
Depreciation $137,000 -15%
Earnings Per Share, Basic -0.05 -400%
Employee-related Liabilities, Current $238,000 +190%
Increase (Decrease) in Accounts Receivable $115,000 -89%
Interest Paid, Excluding Capitalized Interest, Operating Activities $126,000 +241%
Inventory, Net $292,000 -21%
Lessee, Operating Lease, Liability, to be Paid $1,591,000 -6.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four $199,000 +17%
Lessee, Operating Lease, Liability, to be Paid, Year One $335,000 +16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $231,000 -5.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $226,000 -24%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $564,000 -19%
Liabilities $8,752,000 +61%
Liabilities and Equity $8,565,000 -19%
Liabilities, Current $4,932,000 +46%
Net Cash Provided by (Used in) Financing Activities $3,190,000 +268%
Net Cash Provided by (Used in) Investing Activities $32,000
Net Cash Provided by (Used in) Operating Activities $2,917,000 -59%
Nonoperating Income (Expense) $476,000 -656%
Operating Income (Loss) $16,197,000 -198%
Operating Lease, Liability $1,027,000 +2.5%
Operating Lease, Liability, Current $219,000 +109%
Operating Lease, Liability, Noncurrent $808,000 -9.9%
Operating Lease, Right-of-Use Asset $979,000 +1.5%
Other Assets, Noncurrent $108,000 +14%
Preferred Stock, Par or Stated Value Per Share 0.0007 0%
Preferred Stock, Shares Authorized 50,000,000 0%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Outstanding 0
Property, Plant and Equipment, Gross $2,282,000 +3.5%
Property, Plant and Equipment, Net $1,641,000 -3.5%
Research and Development Expense $2,709,000 -6.2%
Retained Earnings (Accumulated Deficit) $163,566,000 -8.6%
Share-based Payment Arrangement, Noncash Expense $699,000 +14%
Stockholders' Equity Attributable to Parent $1,786,000 -77%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $187,000 -104%
Unrecognized Tax Benefits $0

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .